ORASURE TECHNOLOGIES INC
(NASDAQ: OSUR)

OraSure Technologies, Inc., is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company's oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The Company's diagnostic products include tests that are performed on a rapid basis at the point of care and tests that are processed in a laboratory. The Company operates in two segments: OraSure business and DNAG. On August 17, 2011, the Company completed the acquisition of DNA Genotek Inc. (DNAG).

6.130 s

-0.010 (-0.16%)
Range 6.095 - 6.230   (2.21%)
Open -
Previous Close 6.140
Bid Price 5.180
Bid Volume 30
Ask Price 5.450
Ask Volume 14
Volume 1,183,738
Value -
Remark s
Delayed prices. Updated at 29 Mar 2024 03:59.
Data powered by
View All Events

About ORASURE TECHNOLOGIES INC

OraSure Technologies, Inc., is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company's oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The Company's diagnostic products include tests that are performed on a rapid basis at the point of care and tests that are processed in a laboratory. The Company operates in two segments: OraSure business and DNAG. On August 17, 2011, the Company completed the acquisition of DNA Genotek Inc. (DNAG).

Loading Chart...

Please login to view stock data and analysis